These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

705 related articles for article (PubMed ID: 34521025)

  • 21. Why does the Omicron sub-variant spread faster than the original?
    Callaway E
    Nature; 2022 Feb; 602(7898):556-557. PubMed ID: 35177843
    [No Abstract]   [Full Text] [Related]  

  • 22. SARS-CoV-2 reinfection and implications for vaccine development.
    Nainu F; Abidin RS; Bahar MA; Frediansyah A; Emran TB; Rabaan AA; Dhama K; Harapan H
    Hum Vaccin Immunother; 2020 Dec; 16(12):3061-3073. PubMed ID: 33393854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neutralizing SARS-CoV-2.
    Poeschla E
    Elife; 2020 Dec; 9():. PubMed ID: 33320086
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neutralization against Omicron SARS-CoV-2 from previous non-Omicron infection.
    Zou J; Xia H; Xie X; Kurhade C; Machado RRG; Weaver SC; Ren P; Shi PY
    Nat Commun; 2022 Feb; 13(1):852. PubMed ID: 35140233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protection against reinfection with D614- or G614-SARS-CoV-2 isolates in golden Syrian hamster.
    Brustolin M; Rodon J; Rodríguez de la Concepción ML; Ávila-Nieto C; Cantero G; Pérez M; Te N; Noguera-Julián M; Guallar V; Valencia A; Roca N; Izquierdo-Useros N; Blanco J; Clotet B; Bensaid A; Carrillo J; Vergara-Alert J; Segalés J
    Emerg Microbes Infect; 2021 Dec; 10(1):797-809. PubMed ID: 33825619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The coronavirus is here to stay - here's what that means.
    Phillips N
    Nature; 2021 Feb; 590(7846):382-384. PubMed ID: 33594289
    [No Abstract]   [Full Text] [Related]  

  • 27. COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants.
    Jalkanen P; Kolehmainen P; Häkkinen HK; Huttunen M; Tähtinen PA; Lundberg R; Maljanen S; Reinholm A; Tauriainen S; Pakkanen SH; Levonen I; Nousiainen A; Miller T; Välimaa H; Ivaska L; Pasternack A; Naves R; Ritvos O; Österlund P; Kuivanen S; Smura T; Hepojoki J; Vapalahti O; Lempainen J; Kakkola L; Kantele A; Julkunen I
    Nat Commun; 2021 Jun; 12(1):3991. PubMed ID: 34183681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Understanding the outcomes of COVID-19 - does the current model of an acute respiratory infection really fit?
    Simmonds P; Williams S; Harvala H
    J Gen Virol; 2021 Mar; 102(3):. PubMed ID: 33331810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Omicron's lasting mysteries: four questions scientists are racing to answer.
    Dance A
    Nature; 2022 Mar; 603(7899):22-24. PubMed ID: 35210605
    [No Abstract]   [Full Text] [Related]  

  • 30. The great escape? SARS-CoV-2 variants evading neutralizing responses.
    Prévost J; Finzi A
    Cell Host Microbe; 2021 Mar; 29(3):322-324. PubMed ID: 33705702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.
    Garrett ME; Galloway JG; Wolf C; Logue JK; Franko N; Chu HY; Matsen FA; Overbaugh JM
    Elife; 2022 Jan; 11():. PubMed ID: 35072628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterogeneous SARS-CoV-2 kinetics due to variable timing and intensity of immune responses.
    Owens K; Esmaeili S; Schiffer JT
    JCI Insight; 2024 Apr; 9(9):. PubMed ID: 38573774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inactivated SARS-CoV-2 vaccines elicit immunogenicity and T-cell responses in people living with HIV.
    Lv Z; Li Q; Feng Z; Zheng X; NaYin ; Yang H; Gu Q; Ying S; Qi Y; Li X; Wu R; Wu Z; Yu X; Zou N; Qin D; Wan C
    Int Immunopharmacol; 2022 Jan; 102():108383. PubMed ID: 34824035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of Vaccination and Previous Infection on Omicron Infections in Children.
    Lin DY; Gu Y; Xu Y; Zeng D; Wheeler B; Young H; Sunny SK; Moore Z
    N Engl J Med; 2022 Sep; 387(12):1141-1143. PubMed ID: 36069811
    [No Abstract]   [Full Text] [Related]  

  • 35. Serosurvey in BNT162b2 vaccine-elicited neutralizing antibodies against authentic B.1, B.1.1.7, B.1.351, B.1.525 and P.1 SARS-CoV-2 variants.
    Zani A; Caccuri F; Messali S; Bonfanti C; Caruso A
    Emerg Microbes Infect; 2021 Dec; 10(1):1241-1243. PubMed ID: 34092181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low risk of reinfections and relation with serological response after recovery from the first wave of COVID-19.
    Peghin M; Bouza E; Fabris M; De Martino M; Palese A; Bontempo G; Graziano E; Gerussi V; Bressan V; Sartor A; Isola M; Tascini C; Curcio F
    Eur J Clin Microbiol Infect Dis; 2021 Dec; 40(12):2597-2604. PubMed ID: 34378086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serological investigation of asymptomatic cases of SARS-CoV-2 infection reveals weak and declining antibody responses.
    Yang Y; Wang X; Du RH; Zhang W; Si HR; Zhu Y; Shen XR; Li Q; Li B; Men D; Zhou YN; Wang H; Tong XL; Zhang XE; Shi ZL; Zhou P
    Emerg Microbes Infect; 2021 Dec; 10(1):905-912. PubMed ID: 33870851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Omicron (B.1.1.529) - variant of concern - molecular profile and epidemiology: a mini review.
    Kannan S; Shaik Syed Ali P; Sheeza A
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):8019-8022. PubMed ID: 34982466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of Natural Immunity against SARS-CoV-2 Reinfection with the Beta Variant.
    Chemaitelly H; Bertollini R; Abu-Raddad LJ;
    N Engl J Med; 2021 Dec; 385(27):2585-2586. PubMed ID: 34910864
    [No Abstract]   [Full Text] [Related]  

  • 40. Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19.
    Havervall S; Ng H; Jernbom Falk A; Greilert-Norin N; Månberg A; Marking U; Laurén I; Gabrielsson L; Salomonsson AC; Aguilera K; Kihlgren M; Månsson M; Rosell A; Hellström C; Andersson E; Olofsson J; Skoglund L; Yousef J; Pin E; Lord M; Åberg M; Hedhammar M; Tegel H; Dönnes P; Phillipson M; Nilsson P; Klingström J; Mangsbo S; Hober S; Thålin C
    J Intern Med; 2022 Jan; 291(1):72-80. PubMed ID: 34459525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.